Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111.
Budman
Daniel R
DR
Don Monti Division of Oncology, North Shore University Hospital, New York University, Manhasset, NY 11030, USA. budman@nshs.edu
Calabro
Anthony
A
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000633:toxicity; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology* / Q000633:toxicity; D045744:Cell Line, Tumor; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D004357:Drug Synergism; D006131:Growth Inhibitors / Q000633:toxicity*; D006801:Humans; D018055:Receptors, Eicosanoid / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology
D000970:Antineoplastic Agents; D001565:Benzoates; D006131:Growth Inhibitors; C094099:LY 293111; D018055:Receptors, Eicosanoid